Middle East and Africa Clinical Trial Imaging Market – Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET: DBMR MARKET POSITION GRID

2.8 DBMR VENDOR SHARE ANALYSIS

2.9 MULTIVARIATE MODELING

2.10 PRODUCTS LIFELINE CURVE

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING R&D EXPENDITURE

3.1.2 INCREASING NUMBER OF CONTRACT RESEARCH ORGANIZATION

3.1.3 INCREASING PREVALENCE OF CHRONIC DISEASES

3.1.4 GROWTH IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES

3.2 RESTRAINTS

3.2.1 HIGH RISK RADIATION CAUSING DISEASES

3.2.2 HIGH IMPLEMENTATION COST OF IMAGING SYSTEMS

3.3 OPPORTUNITIES

3.3.1 STRATEGIC INITIATIVES FOR BUSINESS EXPANSION

3.3.2 DEVELOPMENT OF INNOVATIVE IMAGING MODALITIES AND CONTRAST AGENTS

3.3.3 EMERGING ECONOMIES

3.4 CHALLENGES

3.4.1 STRICT REGULATORY POLICIES

3.4.2 COST OF CLINICAL TRIALS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES

6.1 OVERVIEW

6.2 SERVICES

6.2.1 OPERATIONAL IMAGING SERVICES

6.2.2 READ ANALYSIS SERVICES

6.2.3 TRIAL DESIGN CONSULTING SERVICES

6.2.4 SYSTEM AND TECHNICAL SUPPORT SERVICES

6.3 SOFTWARE

7 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 ONCOLOGY

7.2.1 ECHOCARDIOGRAPHY

7.2.2 MAGNETIC RESONANCE IMAGING

7.2.3 COMPUTED TOMOGRAPHY

7.2.4 POSITRON EMISSION TOMOGRAPHY

7.2.5 NUCLEAR MEDICINE

7.2.6 X-RAY

7.2.7 ULTRASOUND

7.2.8 OPTICAL COHERENCE TOMOGRAPHY

7.2.9 OTHERS

7.3 NEUROLOGY

7.3.1 COMPUTED TOMOGRAPHY

7.3.2 MAGNETIC RESONANCE IMAGING

7.3.3 POSITRON EMISSION TOMOGRAPHY

7.3.4 NUCLEAR MEDICINE

7.3.5 X-RAY

7.3.6 ULTRASOUND

7.3.7 OPTICAL COHERENCE TOMOGRAPHY

7.3.8 OTHERS

7.4 ENDOCRINOLOGY

7.4.1 COMPUTED TOMOGRAPHY

7.4.2 MAGNETIC RESONANCE IMAGING

7.4.3 POSITRON EMISSION TOMOGRAPHY

7.4.4 NUCLEAR MEDICINE

7.4.5 X-RAY

7.4.6 ULTRASOUND

7.4.7 OPTICAL COHERENCE TOMOGRAPHY

7.4.8 OTHERS

7.5 CARDIOLOGY

7.5.1 X-RAY

7.5.2 ULTRASOUND

7.5.3 COMPUTED TOMOGRAPHY

7.5.4 MAGNETIC RESONANCE IMAGING

7.5.5 NUCLEAR MEDICINE

7.5.6 POSITRON EMISSION TOMOGRAPHY

7.5.7 OPTICAL COHERENCE TOMOGRAPHY

7.5.8 ECHOCARDIOGRAPHY

7.5.9 OTHERS

7.6 DERMATOLOGY

7.6.1 ULTRASOUND

7.6.2 X-RAY

7.6.3 MAGNETIC RESONANCE IMAGING

7.6.4 COMPUTED TOMOGRAPHY

7.6.5 OPTICAL COHERENCE TOMOGRAPHY

7.6.6 POSITRON EMISSION TOMOGRAPHY

7.6.7 NUCLEAR MEDICINE

7.6.8 OTHERS

7.7 HEMATOLOGY

7.7.1 ULTRASOUND

7.7.2 COMPUTED TOMOGRAPHY

7.7.3 MAGNETIC RESONANCE IMAGING

7.7.4 X-RAY

7.7.5 POSITRON EMISSION TOMOGRAPHY

7.7.6 NUCLEAR MEDICINE

7.7.7 OPTICAL COHERENCE TOMOGRAPHY

7.7.8 ECHOCARDIOGRAPHY

7.7.9 OTHERS

8 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY MODALITY

8.1 OVERVIEW

8.2 COMPUTED TOMOGRAPHY

8.3 MAGNETIC RESONANCE IMAGING

8.4 ULTRASOUND

8.5 POSITRON EMISSION TOMOGRAPHY

8.6 X-RAY

8.7 ECHOCARDIOGRAPHY

8.8 NUCLEAR MEDICINE

8.9 OPTICAL COHERENCE TOMOGRAPHY

8.10 OTHERS

9 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY END USER

9.1 OVERVIEW

9.2 CONTRACT RESEARCH ORGANIZATION

9.3 MEDICAL DEVICE MANUFACTURERS

9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

9.5 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES

10 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR

10.1 OVERVIEW

10.2 DIRECT SALES

10.3 TENDERS SALES

11 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY GEOGRAPHY

11.1 MIDDLE EAST AND AFRICA

11.1.1 SAUDI ARABIA

11.1.2 SOUTH AFRICA

11.1.3 REST OF MEA

11.1.3 EGYPT

11.1.4 SAUDI ARAIA

11.1.5 UNITED ARAB EMIRATES

11.1.6 ISRAEL

12 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

13 COMPANY PROFILE

13.1 NAVITAS LIFE SCIENCES

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 SERVICE PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.2 RESONANCE HEALTH

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 SERVICE PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.3 BIOTELEMETRY, INC.

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 SERVICEPORTFOLIO

13.3.5 RECENT DEVELOPMENTS

13.4 IXICO PLC

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 SERVICE PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.5 ICON PLC

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 SERVICE PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.6 IMAGE CORE LAB

13.6.1 COMPANY SNAPSHOT

13.6.2 SERVICE PORTFOLIO

13.6.3 RECENT DEVELOPMENT

13.7 ANAGRAM 4 CLINICAL TRIALS

13.7.1 COMPANY SNAPSHOT

13.7.2 SERVICE PORTFOLIO

13.7.3 RECENT DEVELOPMENT

13.8 BIOCLINICA

13.8.1 COMPANY SNAPSHOT

13.8.2 SERVICE PORTFOLIO

13.8.3 RECENT DEVELOPMENTS

13.9 CARDIOVASCULAR IMAGING TECHNOLOGIES

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENT

13.10 ERT CLINICAL

13.10.1 COMPANY SNAPSHOT

13.10.2 SERVICE PORTFOLIO

13.10.3 RECENT DEVELOPMENTS

13.11 INTRINSIC IMAGING

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 SERVICE PORTFOLIO

13.11.4 RECENT DEVELOPMENTS

13.12 LYSCAUT MEDICAL IMAGING COMPANY

13.12.1 COMPANY SNAPSHOT

13.12.2 SERVICE PORTFOLIO

13.12.3 RECENT DEVELOPMENT

13.13 PAREXEL INTERNATIONAL CORPORATION

13.13.1 COMPANY SNAPSHOT

13.13.2 SERVICE PORTFOLIO

13.13.3 RECENT DEVELOPMENTS

13.14 PERSPECTUM DIAGNOSTICS

13.14.1 COMPANY SNAPSHOT

13.14.2 PRODUCT PORTFOLIO

13.14.3 SERVICE PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 QUOTIENT SCIENCES

13.15.1 COMPANY SNAPSHOT

13.15.2 SERVICE PORTFOLIO

13.15.3 RECENT DEVELOPMENTS

13.16 RADIANT SAGE LLC

13.16.1 COMPANY SNAPSHOT

13.16.2 PRODUCT PORTFOLIO

13.16.3 SERVICE PORTFOLIO

13.16.4 RECENT DEVELOPMENTS

13.17 WORLDCARE CLINICAL

13.17.1 COMPANY SNAPSHOT

13.17.2 SERVICE PORTFOLIO

13.17.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

UU

TABLE 1 COST OF CLINICAL TRIAL PHASE 2 AND PHASE 3

TABLE 2 HUGE R&D COST IN THE U.S. FOR DIFFERENT PHASES

TABLE 3 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES, 2017-2026 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA SERVICES IN CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA SOFTWARE CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 8 ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA NEUROLOGYI N CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA ENDOCRINOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA CARDIOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA DERMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA HEMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA COMPUTED TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA MAGNETIC RESONANCE IMAGING IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA ULTRASOUND IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA POSITRON EMISSION TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA X-RAY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA ECHOCARDIOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA OPTICAL COHERENCE TOMOGRAPHYIN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA OTHERS SEGMENTS IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA MEDICAL DEVICE MANUFACTURERS COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES IN CLINICAL TRIAL IMAGINGMARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA DIRECT SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA TENDERS SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA NEUROLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION,2017-2026 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 51 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 52 SAUDI ARABIA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 53 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 54 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 55 SAUDI ARABIA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 56 SAUDI ARABIA NEUROLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 57 SAUDI ARABIA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 58 SAUDI ARABIA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 59 SAUDI ARABIA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 60 SAUDI ARABIA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 61 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 62 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 63 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 64 SOUTH AFRICA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 65 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 66 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 67 SOUTH AFRICA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 68 SOUTH AFRICA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 69 SOUTH AFRICA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 70 SOUTH AFRICA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 71 SOUTH AFRICA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 72 SOUTH AFRICA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 73 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 74 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 75 REST OF MEA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)